CN102415993B - 一种盐酸纳美芬药物组合物及其制备方法 - Google Patents
一种盐酸纳美芬药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN102415993B CN102415993B CN 201110395606 CN201110395606A CN102415993B CN 102415993 B CN102415993 B CN 102415993B CN 201110395606 CN201110395606 CN 201110395606 CN 201110395606 A CN201110395606 A CN 201110395606A CN 102415993 B CN102415993 B CN 102415993B
- Authority
- CN
- China
- Prior art keywords
- injection
- nalmefene hydrochloride
- water
- nalmefene
- hydrochloric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
反应级 | 刺激反应 |
0 | 无明显变化 |
1 | 血管变化限于耳缘静脉,可能有坏死或栓塞也可见中度水肿,纤维蛋白沉积或出血 |
2 | 变化类似1,水肿,纤维蛋白沉积,出血或炎细胞侵润扩展至半只耳壳 |
3 | 变化类似2,但耳缘静脉以外的静脉也有栓塞或/和坏死,水肿,纤维蛋白沉积,出血或炎细胞侵润扩展至半只耳壳以上,但栓塞坏死限于半只耳壳 |
4 | 变化类似3,但病变扩展至2/3耳壳 |
5 | 变化类似4,但全耳发生弥漫性变化 |
组 别 | 致敏剂量 | 激发剂量 | 过敏反应情况 |
阴 性 对 照 组 | 0.5mL/只 | 1mL/只 | 0/6 |
盐酸纳美芬注射液 | 0.5mL/只 | 1mL/只 | 0/6 |
马血清阳性对照组 | 0.1mL/只 | 0.2mL/只 | 6/6 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110395606 CN102415993B (zh) | 2011-12-03 | 2011-12-03 | 一种盐酸纳美芬药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110395606 CN102415993B (zh) | 2011-12-03 | 2011-12-03 | 一种盐酸纳美芬药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102415993A CN102415993A (zh) | 2012-04-18 |
CN102415993B true CN102415993B (zh) | 2013-01-09 |
Family
ID=45940797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110395606 Active CN102415993B (zh) | 2011-12-03 | 2011-12-03 | 一种盐酸纳美芬药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102415993B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040733B (zh) * | 2012-07-12 | 2014-02-26 | 姚云 | 一种含有盐酸纳美芬化合物的药物组合物 |
CN106214634A (zh) * | 2016-08-31 | 2016-12-14 | 安徽省润生医药股份有限公司 | 一种福司氟康唑注射液及其制备方法 |
CN106727293A (zh) * | 2016-12-12 | 2017-05-31 | 河南润弘制药股份有限公司 | 一种盐酸纳美芬注射液及其制备方法 |
CN110269837B (zh) * | 2019-07-19 | 2020-04-10 | 广东奇方药业有限公司 | 盐酸纳洛酮注射液及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987002586A2 (en) * | 1985-10-29 | 1987-05-07 | Key Pharmaceuticals, Inc. | Method and composition for blocking antigen-induced allergic responses |
CN1895251A (zh) * | 2005-07-13 | 2007-01-17 | 汕头大学医学院 | 稳定的盐酸纳美芬注射液及其制备方法 |
CN101406474A (zh) * | 2008-02-28 | 2009-04-15 | 云南绿野生物医药有限公司 | 纳美芬注射液及其制备方法 |
CN101658489A (zh) * | 2008-08-27 | 2010-03-03 | 海南四环心脑血管药物研究院有限公司 | 一种盐酸纳美芬注射液及其制备方法 |
CN101658488A (zh) * | 2008-08-27 | 2010-03-03 | 海南四环心脑血管药物研究院有限公司 | 盐酸纳美芬注射液及其制备方法 |
-
2011
- 2011-12-03 CN CN 201110395606 patent/CN102415993B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987002586A2 (en) * | 1985-10-29 | 1987-05-07 | Key Pharmaceuticals, Inc. | Method and composition for blocking antigen-induced allergic responses |
CN1895251A (zh) * | 2005-07-13 | 2007-01-17 | 汕头大学医学院 | 稳定的盐酸纳美芬注射液及其制备方法 |
CN101406474A (zh) * | 2008-02-28 | 2009-04-15 | 云南绿野生物医药有限公司 | 纳美芬注射液及其制备方法 |
CN101658489A (zh) * | 2008-08-27 | 2010-03-03 | 海南四环心脑血管药物研究院有限公司 | 一种盐酸纳美芬注射液及其制备方法 |
CN101658488A (zh) * | 2008-08-27 | 2010-03-03 | 海南四环心脑血管药物研究院有限公司 | 盐酸纳美芬注射液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102415993A (zh) | 2012-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Reissmann et al. | On the presence of ferritin in the peripheral blood of patients with hepatocellular disease | |
Gordon et al. | Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter | |
Gonçalves et al. | Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown | |
Wright et al. | Deaths Involving Methylenedioxypyrovalerone (MDPV) in Upper E ast T ennessee | |
CN102415993B (zh) | 一种盐酸纳美芬药物组合物及其制备方法 | |
CN109661241A (zh) | 使用识别凝血因子ix和/或活化凝血因子ix以及凝血因子x和/或活化凝血因子x的双特异性抗体的方法 | |
CN102552294B (zh) | 一种注射用复方维生素冻干粉针剂组合物 | |
Dingman et al. | Studies of neurohypophyseal function in man: diabetes insipidus and psychogenic polydipsia | |
CN105748420B (zh) | 一种治疗心力衰竭的lcz696缓释骨架片的制备方法 | |
CN103463565B (zh) | 一种莪术油注射液及其制备方法 | |
CN103735500A (zh) | 盐酸他喷他多注射液及其制备方法 | |
Comaish et al. | Site of action of methotrexate in psoriasis | |
CN103462885A (zh) | 一种稳定的罗库溴铵注射液制剂及其制备方法 | |
Intoxication–La Rosa | Brodifacoum intoxication with marijuana smoking | |
McClain et al. | Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: results of a phase 2, randomized, blinded, controlled trial | |
Lucas et al. | Disposition of vancomycin in healthy volunteers from oral solution and semi‐solid matrix capsules | |
CN104645312B (zh) | 一种含有科博肽和羟考酮的复方镇痛制剂 | |
CN108066339B (zh) | 一种帕瑞昔布钠的药物组合物 | |
CN108125963B (zh) | 聚普瑞锌直肠给药制剂及制备溃疡性结肠炎药物的应用 | |
CN107157924A (zh) | 萘普生钠氯化钠注射液及其制备方法 | |
Francisco et al. | In vitro and in vivo bioequivalence of commerical prednisone tablets | |
CN103655460B (zh) | 一种含氨曲南的注射用药物组合物及其制备方法和用途 | |
US20220332676A1 (en) | Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for intravenous administration and the use thereof | |
CN102621335A (zh) | 一种血液制品及其制备方法 | |
US20230372294A1 (en) | Lyophilized composition comprising (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 430074 Hubei city of Wuhan province Wu East Lake Development Zone of Hubei Bay Industrial Information Technology Building Room 1602 Patentee after: Tongyuan Pharmaceutical Ind Co., Ltd., Wuhan Address before: 430071 Hubei Province, Wuhan city Wuchang District Road No. 100 3 unit 101 purple Patentee before: Tongyuan Pharmaceutical Ind Co., Ltd., Wuhan |
|
ASS | Succession or assignment of patent right |
Owner name: BIOCHEMICAL PHARMACEUTICAL FACTORY, ZHUHAI SPECIAL Free format text: FORMER OWNER: TONGYUAN PHARMACEUTICAL IND CO., LTD., WUHAN Effective date: 20131226 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430074 WUHAN, HUBEI PROVINCE TO: 519041 ZHUHAI, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131226 Address after: 519041 Guangdong province Zhuhai Sanzao Jinhai Road No. 6 Patentee after: Biochemical Pharmaceutical Factory of Zhuhai S.E.Z. Address before: 430074 Hubei city of Wuhan province Wu East Lake Development Zone of Hubei Bay Industrial Information Technology Building Room 1602 Patentee before: Tongyuan Pharmaceutical Ind Co., Ltd., Wuhan |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 519041 Guangdong province Zhuhai Sanzao Jinhai Road No. 6 Patentee after: Zhuhai homologous Pharmaceutical Co., Ltd. Address before: 519041 Guangdong province Zhuhai Sanzao Jinhai Road No. 6 Patentee before: Biochemical Pharmaceutical Factory of Zhuhai S.E.Z. |